Close

Leerink Swann Maintains an 'Outperform' on Verastem (VSTM); Potential Leadership Position in FAK Inhibition

July 13, 2012 10:33 AM EDT Send to a Friend
Leerink Swann maintains an 'Outperform' on Verastem (NASDAQ: VSTM).

Analyst, Howard Liang, said, "We are impressed with the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login